Total Payments
$1,584
2024 Payments
$552.10
Companies
16
Transactions
33
Payment Breakdown by Category
Food & Beverage$1,190 (75.1%)
Education$393.95 (24.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,190 | 29 | 75.1% |
| Education | $393.95 | 4 | 24.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $348.96 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $244.09 | 5 | $0 (2024) |
| ABBVIE INC. | $150.00 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $138.91 | 2 | $0 (2023) |
| Incyte Corporation | $129.76 | 2 | $0 (2023) |
| Kite Pharma, Inc. | $110.37 | 4 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $96.00 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $95.23 | 3 | $0 (2024) |
| Amgen Inc. | $81.83 | 4 | $0 (2023) |
| Genmab U.S., Inc. | $48.24 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $552.10 | 16 | AstraZeneca Pharmaceuticals LP ($244.09) |
| 2023 | $509.28 | 10 | ABBVIE INC. ($150.00) |
| 2022 | $482.55 | 6 | Seagen Inc. ($348.96) |
| 2021 | $39.91 | 1 | Janssen Biotech, Inc. ($39.91) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: CELLT | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: CELLT | ||||||
| 09/24/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: CELLT | ||||||
| 09/13/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: CELLT | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Infectious Diseases | ||||||
| 06/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Rare Disease | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Infectious Diseases | ||||||
| 05/13/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Oncology | ||||||
| 04/29/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Oncology | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: Infectious Diseases | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Education | In-kind items and services | $96.00 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $27.25 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 07/17/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 06/20/2023 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $29.81 | General |
| Category: Oncology | ||||||
| 03/11/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $23.49 | General |
| 02/16/2023 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Oncology | ||||||
| 02/09/2023 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Oncology | ||||||
About Renatta Jacobs
Renatta Jacobs is a Primary Care healthcare provider based in Lodi, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2020. The National Provider Identifier (NPI) number assigned to this provider is 1235725326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Renatta Jacobs has received a total of $1,584 in payments from pharmaceutical and medical device companies, with $552.10 received in 2024. These payments were reported across 33 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,190).
Ad
Practice Information
- Specialty Primary Care
- Location Lodi, NJ
- Active Since 12/14/2020
- Last Updated 12/14/2020
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235725326
Products in Payments
- ADCETRIS (Biological) $249.96
- CALQUENCE (Drug) $244.09
- IMBRUVICA (Drug) $195.00
- EPKINLY (Drug) $150.00
- MONJUVI (Drug) $141.83
- Yescarta (Drug) $110.37
- Cresemba (Drug) $95.23
- Blincyto (Biological) $60.26
- Epkinly (Drug) $48.24
- DARZALEX (Biological) $39.91
- SYLVANT (Drug) $28.83
- BAVENCIO (Drug) $27.25
- ULTOMIRIS (Biological) $25.34
- LUMAKRAS (Drug) $21.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.